PPT-New Antiretroviral Drugs in Development and Novel ART Regimens
Author : paisley | Published Date : 2024-07-01
Constance A Benson MD Professor of Medicine and Global Public Health University of California San Diego La Jolla California Goals for the Workshop To describe the
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "New Antiretroviral Drugs in Development ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
New Antiretroviral Drugs in Development and Novel ART Regimens: Transcript
Constance A Benson MD Professor of Medicine and Global Public Health University of California San Diego La Jolla California Goals for the Workshop To describe the potential benefits of longacting antiretroviral drugs ARVs for treatment and prevention of HIV infection. KGMU. Top five states in India which have highest number of leprosy cases. State 2009-10 2010-11 2011-12 2012-13. Uttar Pradesh 27,473 25,509 24,627 24,222. Scott K. . Heysell. MD, MPH. (no disclosures). Why do we need new drugs/ regimens?. ▪Isoniazid and pyrazinamide remain some of the most . toxic. antibiotics prescribed for infectious disease . -. John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. Albany Medical Center Hospital. NY/NJ AIDS Education and Training Center. When to Start. DHHS: Changing Criteria for Initiating ART. CD4+ Count, cells/mm. Scott K. . Heysell. MD, MPH. (no disclosures). Why do we need new drugs/ regimens?. ▪Isoniazid and pyrazinamide remain some of the most . toxic. antibiotics prescribed for infectious disease . -. Danielle Goodrich, MSIV. University of Maryland School of Medicine . Overview. Colorectal Cancer. Bowel Preparation Regimens. Survey. 2. Colorectal Cancer . Third most common cancer. Second leading cause of cancer-related deaths. Rates of VTE* in Newly Diagnosed MM . Treatment. No Prophylaxis. Any Prophylaxis. ASA. Warfarin. 1-1.25 mg/d. Prophylactic LMWH. Therapeutic Anticoagulation. T alone . (95% CI) . 1.3 . (0.4–2.7) . KGMU. Top five states in India which have highest number of leprosy cases. State 2009-10 2010-11 2011-12 2012-13. Uttar Pradesh 27,473 25,509 24,627 24,222. Learning Objectives. Understand when to switch to a second-line regimen. Know preferred second-line regimens for adults (including pregnant and breastfeeding women), adolescents, and children. Describe common drug resistance mutations and how they influence choosing a second-line regimen. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Drew Lambert, . PharmD. lambertd@husson.edu. Husson University School of Pharmacy. 1. I have no conflicts of interest.. However, I will be using brand names extensively during the presentation. Majority of the drugs used are brand-only. G-103 Ckbeceopap (Pubkop( CO>E) (Last updated December 24, 2019, last reviewed December 24, 2019)Carcinogenicity Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infectio www.hivguidelines.org. Purpose of . This Guideline. Provide a clear and concise roadmap for clinicians to follow in choosing from among several equally efficacious ART regimens based on individual patient characteristics and preferences.. (Last updated December 30, 2021; last reviewed December 30, 2021) Panels Recommendations When acute HIV infection is suspected in pregnancy or during breastfeeding, a plasma HIV RNA test should Anastasiya Nestsiarovich, MD, PhD. Postdoctoral Fellow. University of New . Mexico Health Sciences Center. Department of Internal . Medicine. Center . for Global . Health. September 16, 2019. Research team:.
Download Document
Here is the link to download the presentation.
"New Antiretroviral Drugs in Development and Novel ART Regimens"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents